CHARLESTON — The House of Delegates passed a bill that would remove narrow exceptions meant to allow minors going through gender dysphoria to be treated with minimum dosages of medication if they are at risk of hurting themselves or others. House Bill 5297 passed 88-11 and now goes to ...
by Rekha Basu Ajit “Ayaan” Sharma, a skinny 11-year-old with dark eyes that gleam like headlights, bounces around a New Delhi home on the balls of his feet. He exudes an energetic spunk for a kid living with only one working lung — and that functioning at only 40% — because of ...
by Lisa Jarvis New data from an experimental drug being developed by Eli Lilly & Co. raises an intriguing question about obesity treatments: How low can the weight loss go? For a subset of patients in a mid-stage study of retatrutide, the answer seems to be very, very ...
by Lisa Jarvis A Texas federal judge’s ruling to remove the 23-year-old drug mifepristone from the market not only threatens abortion access in the U.S. — it’s also an appalling sideswipe at the Food and Drug Administration’s authority and expertise. And if allowed to ...
In rejecting the pared down Build Back Better Act, Sen. Joe Manchin made clear that the only provision he still supports is codifying Medicare’s ability to negotiate prescription drug costs. Such a law would undoubtedly help hundreds, if not thousands, of West Virginians to contain the ...
Mindy Salango is a Morgantown resident who lives with Type 1 diabetes. Salango is a mom, has a full-time job with health insurance and still struggles to afford her medications. She said she pays about $350 a month for her life-saving insulin and daily supplies. Salango has been a ...